Adaptive Biotechnologies vs Zynerba Pharmaceuticals
Adaptive Biotechnologies vs Zynerba Pharmaceuticals, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Zynerba Pharmaceuticals on 38/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 38/100
- agent readiness: 39/100 against 22/100
- domain rating: 62/100 against 40/100
Zynerba Pharmaceuticals
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adaptive Biotechnologies | Zynerba Pharmaceuticals |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Pharmaceutical company developing transdermal cannabinoid therapeutics for behavioral and emotional conditions. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Biotech, MedTech, Drug Discovery, Clinical Trials |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Services |
| Founded | 2009 | 2007 |
| Headquarters | Seattle, United States | Wayne, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Zynerba Pharmaceuticals |
|---|---|---|
| Total funding | $300M | Not published |
| Latest round | Series D | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Zynerba Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 38/100 |
| Team | Not published | 30/100 |
| Community | Not published | 15/100 |
| Search visibility | Not published | 2/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 62/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Zynerba Pharmaceuticals |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Google Tag Manager |
Adaptive Biotechnologies vs Zynerba Pharmaceuticals: common questions
Which is better, Adaptive Biotechnologies or Zynerba Pharmaceuticals?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Zynerba Pharmaceuticals compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 38/100), agent readiness (39/100 against 22/100), domain rating (62/100 against 40/100).
Read the full Adaptive Biotechnologies review and pricing or the Zynerba Pharmaceuticals review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.